Revenue
Revenue Recognized from Contract Liabilities
Vertex Pharmaceuticals Revenue Recognized from Contract Liabilities remained flat by 0.0% to $51.70M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 21.4%, from $42.58M to $51.70M. Over 2 years (FY 2023 to FY 2025), Revenue Recognized from Contract Liabilities shows an upward trend with a 13.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionRevenue
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
How to read this metric
Consistent recognition of deferred revenue indicates a healthy pipeline of service delivery and stable business operations.
Detailed definition
This metric tracks the portion of revenue recognized during the period that was previously recorded as deferred revenue...
Peer comparison
Commonly analyzed for SaaS and subscription-based business models.
Metric ID:
isrg_contract_liability_revenue_recognizedHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $159.60M | $170.30M | $206.80M |
| YoY Change | — | +6.7% | +21.4% |
Range$159.60M – $206.80M
CAGR+13.8%
Avg YoY Growth+14.1%
Median YoY Growth+14.1%
Current Streak2+ years growth
Revenue Recognized from Contract Liabilities at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's revenue recognized from contract liabilities?
- Vertex Pharmaceuticals (VRTX) reported revenue recognized from contract liabilities of $51.70M in Q4 2025.
- How has Vertex Pharmaceuticals's revenue recognized from contract liabilities changed year-over-year?
- Vertex Pharmaceuticals's revenue recognized from contract liabilities increased by 21.4% year-over-year, from $42.58M to $51.70M.
- What is the long-term trend for Vertex Pharmaceuticals's revenue recognized from contract liabilities?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's revenue recognized from contract liabilities has grown at a 13.8% compound annual growth rate (CAGR), from $159.60M to $206.80M.
- What does revenue recognized from contract liabilities mean?
- Revenue recognized this period that was previously held as deferred revenue.